In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a CellCept, RS 61443, TM-MMF, Mycophenolate mofetil Drug Master File in Korea (CellCept, RS 61443, TM-MMF, Mycophenolate mofetil KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of CellCept, RS 61443, TM-MMF, Mycophenolate mofetil. The MFDS reviews the CellCept, RS 61443, TM-MMF, Mycophenolate mofetil KDMF as part of the drug registration process and uses the information provided in the CellCept, RS 61443, TM-MMF, Mycophenolate mofetil KDMF to evaluate the safety and efficacy of the drug.
After submitting a CellCept, RS 61443, TM-MMF, Mycophenolate mofetil KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their CellCept, RS 61443, TM-MMF, Mycophenolate mofetil API can apply through the Korea Drug Master File (KDMF).
click here to find a list of CellCept, RS 61443, TM-MMF, Mycophenolate mofetil suppliers with KDMF on PharmaCompass.